BIVV

Bioverativ Inc. Common Stock
BIVV

Overview Fund Activity
Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

445 hedge funds and large institutions have $5.89B invested in Bioverativ Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 148 increasing their positions, 149 reducing their positions, and 56 closing their positions.

Holders
445
Holders Change
-6
Holders Change %
-1.33%
% of All Funds
11.11%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
53
Increased
148
Reduced
149
Closed
56
Calls
$13.6M
Puts
$21.9M
Net Calls
-$8.3M
Net Calls Change
-$10.8M

Top Buyers

1
JIM
1
Jupiter Investment Management
United Kingdom
$96.8M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$216M
3
Jennison Associates
3
Jennison Associates
New York
$56.4M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$45.9M
5
Goldman Sachs
5
Goldman Sachs
New York
$131M

Top Sellers

1
VH
1
ValueAct Holdings
California
$72.5M
2
HM
2
HealthCor Management
New York
$237M
3
Two Sigma Investments
3
Two Sigma Investments
New York
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$205M
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$59.1M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$529M 9,277,997 -109,411 -1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$511M 8,960,021 +163,614 +2%
Primecap Management
3
Primecap Management
California
$436M 7,642,976 -56,762 -0.7%
State Street
4
State Street
Massachusetts
$253M 4,440,528 +270,239 +6%
HM
5
HealthCor Management
New York
$237M 4,150,000 -2,325,000 -36%
ClearBridge Investments
6
ClearBridge Investments
New York
$219M 3,832,722 -36,551 -0.9%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$216M 3,787,380 +1,294,586 +52%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$205M 3,596,521 -274,761 -7%
Goldman Sachs
9
Goldman Sachs
New York
$131M 2,300,429 +716,021 +45%
Wells Fargo
10
Wells Fargo
California
$125M 2,181,516 +533,731 +32%
WIM
11
Woodford Investment Management
United Kingdom
$112M 1,960,325 -17,439 -0.9%
JSP
12
Jackson Square Partners
California
$99.3M 1,740,607 -116,849 -6%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$97.1M 1,700,839 +201,557 +13%
JIM
14
Jupiter Investment Management
United Kingdom
$96.8M 1,696,638 +1,371,016 +421%
PI
15
Putnam Investments
Massachusetts
$87.5M 1,533,622 +496,224 +48%
AQR Capital Management
16
AQR Capital Management
Connecticut
$87.5M 1,532,988 +594,098 +63%
Arrowstreet Capital
17
Arrowstreet Capital
Massachusetts
$86.2M 1,509,634 +620,417 +70%
VH
18
ValueAct Holdings
California
$72.5M 1,270,619 -5,893,273 -82%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$71M 1,244,630 +20,316 +2%
Norges Bank
20
Norges Bank
Norway
$64.4M 1,127,692 -44,943 -4%
Janus Henderson Group
21
Janus Henderson Group
United Kingdom
$60M 1,051,451 +321,136 +44%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$59.1M 1,036,052 -249,218 -19%
MWNA
23
Marshall Wace North America
New York
$58.6M 1,028,827 +375,855 +58%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$57.4M 1,006,146 +104,513 +12%
CCM
25
Camber Capital Management
Massachusetts
$57.1M 1,000,000 -174,300 -15%
1
2 3 4 5